These dying patients cannot get experimental drugs

Autumn Fuernisen was diagnosed four years ago with a terminal brain disorder, juvenile-onset Huntington's disease. Patients with rare diseases often have difficulty qualifying for compassionate use programs for experimental therapies.- Londen Tabor/TNS

AT 15, Autumn Fuernisen is dying.

She was diagnosed at age 11 with a rare degenerative brain disorder that has no known cure or way to slow it down: juvenile-onset Huntington’s disease.